IU School of Medicine Chosen for COVID Vaccine Trial
The Indiana University School of Medicine in Indianapolis has been selected as one of dozens of sites for a COVID-19 vaccine trial. United Kingdom-based AstraZeneca plc (NYSE: AZN) is conducting the Phase III clinical trial of the vaccine, which researchers at Oxford University began developing in [点击 More>>>]